Diltiazem and hydrochlorothiazide are widely used to treat cardiovascular disease, often in combination. The purpose of this investigation was to determine whether a drug -drug pharmacokinetic interaction exists between diltiazem and hydrochlorothiazide. In a randomized, crossover, open study, multi
✦ LIBER ✦
Single-Dose and Steady-State Pharmacokinetics of Diltiazem Administered in Two Different Tablet Formulations
✍ Scribed by Christrup, Lona L. ;Bonde, Jan ;Rasmussen, Søren N. ;Sonnergaard, Jørn Møller ;Jensen, Bodil H.
- Book ID
- 114801892
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 310 KB
- Volume
- 71
- Category
- Article
- ISSN
- 0901-9928
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Steady-state pharmacokinetics of diltiaz
✍
Scott J. Weir; Dan C. Dimmitt; Robert C. Lanman; M. Bruce Morrill; Dennis H. Gei
📂
Article
📅
1998
🏛
John Wiley and Sons
🌐
English
⚖ 159 KB
👁 2 views
Single-dose and steady-state pharmacokin
✍
Stempak, D
📂
Article
📅
2002
🏛
Nature Publishing Group
🌐
English
⚖ 115 KB
Comparative steady state serum levels of
✍
Svein I. Johannessen; Olaf Henriksen
📂
Article
📅
1979
🏛
John Wiley and Sons
🌐
English
⚖ 185 KB
Assessment of the steady-state pharmacok
✍
TN Kakuda; M Schöller-Gyüre; G De Smedt; G Beets; F Aharchi; MP Peeters; K Vande
📂
Article
📅
2009
🏛
John Wiley and Sons
🌐
English
⚖ 180 KB
Single intravenous dose and steady-state
✍
John G. Wagner; Teck L. Ling; Edward J. Mroszczak; Donna Freedman; Ann Wu; Bee H
📂
Article
📅
1987
🏛
John Wiley and Sons
🌐
English
⚖ 617 KB
Nicardipine HCI oral doses (10-40 mg) were administered sequentially to six healthy subjects. For each regimen the capsule dose was administered every 8 hours (q 8 h) for 3 days and the plasma profiles of nicardipine and its pyridine analogue (M5) were determined following the last dose on day 4. St
Single-dose and steady-state pharmacokin
✍
A. Darragh; A. J. Gordon; H. O'Byrne; D. Hobbs; E. Casey
📂
Article
📅
1985
🏛
Springer
🌐
English
⚖ 594 KB